中华器官移植杂志
中華器官移植雜誌
중화기관이식잡지
CHINESE JOURNAL OF ORGAN TRANSPLANTATION
2012年
4期
246-249
,共4页
邱月%戚贵生%杨橙%赵天%许明%薛寅佳%赵梓彤%林淼%邱甬鄞%戎瑞明%朱同玉
邱月%慼貴生%楊橙%趙天%許明%薛寅佳%趙梓彤%林淼%邱甬鄞%戎瑞明%硃同玉
구월%척귀생%양등%조천%허명%설인가%조재동%림묘%구용은%융서명%주동옥
大鼠%骨髓%间质干细胞%肾%再灌注损伤
大鼠%骨髓%間質榦細胞%腎%再灌註損傷
대서%골수%간질간세포%신%재관주손상
Rats%Bone marrow%Mesenchymal stem cells%Kidney%Reperfusion injury
目的 观察不同时间输注骨髓间充质干细胞(MSC)对大鼠肾脏缺血再灌注损伤(IRI)的影响.方法 以切除一侧肾脏夹闭对侧肾血管的方法制备肾IRI大鼠模型,3个实验组分别于恢复肾血流前2 h(灌前组)、恢复肾血流即刻(即刻组)和恢复肾血流6h时(灌后组)经尾静脉注射经荧光染料标记的MSC 2×106个,并设不输注MSC的对照组(IR组)和假手术对照组(假手术组).观察输注MSC后6h肾组织中MSC的分布情况;检测再灌注后6、24和48 h的血肌酐(Cr)和尿素氮(BUN)水平;观察再灌注后48 h的肾组织病理改变和肾小管上皮细胞凋亡情况.结果 输注MSC者均可在肾脏中观察到MSC,以灌后组最多(P<0.05).再灌注后24 h和48 h时,输注MSC者的血Cr和BUN与假手术组比较,差异均无统计学意义(P>0.05),但均明显低于IR组(P<0.05).与IR组比较,输注MSC者的肾脏病理损伤减轻,细胞凋亡数减少,以灌后组的改善最为明显(P<0.05).结论输注MSC可减轻大鼠肾脏的IRI,这一效应在再灌注后输注MSC者最为明显,可能是通过减轻炎症反应和抑制肾小管细胞凋亡来减轻IRI.
目的 觀察不同時間輸註骨髓間充質榦細胞(MSC)對大鼠腎髒缺血再灌註損傷(IRI)的影響.方法 以切除一側腎髒夾閉對側腎血管的方法製備腎IRI大鼠模型,3箇實驗組分彆于恢複腎血流前2 h(灌前組)、恢複腎血流即刻(即刻組)和恢複腎血流6h時(灌後組)經尾靜脈註射經熒光染料標記的MSC 2×106箇,併設不輸註MSC的對照組(IR組)和假手術對照組(假手術組).觀察輸註MSC後6h腎組織中MSC的分佈情況;檢測再灌註後6、24和48 h的血肌酐(Cr)和尿素氮(BUN)水平;觀察再灌註後48 h的腎組織病理改變和腎小管上皮細胞凋亡情況.結果 輸註MSC者均可在腎髒中觀察到MSC,以灌後組最多(P<0.05).再灌註後24 h和48 h時,輸註MSC者的血Cr和BUN與假手術組比較,差異均無統計學意義(P>0.05),但均明顯低于IR組(P<0.05).與IR組比較,輸註MSC者的腎髒病理損傷減輕,細胞凋亡數減少,以灌後組的改善最為明顯(P<0.05).結論輸註MSC可減輕大鼠腎髒的IRI,這一效應在再灌註後輸註MSC者最為明顯,可能是通過減輕炎癥反應和抑製腎小管細胞凋亡來減輕IRI.
목적 관찰불동시간수주골수간충질간세포(MSC)대대서신장결혈재관주손상(IRI)적영향.방법 이절제일측신장협폐대측신혈관적방법제비신IRI대서모형,3개실험조분별우회복신혈류전2 h(관전조)、회복신혈류즉각(즉각조)화회복신혈류6h시(관후조)경미정맥주사경형광염료표기적MSC 2×106개,병설불수주MSC적대조조(IR조)화가수술대조조(가수술조).관찰수주MSC후6h신조직중MSC적분포정황;검측재관주후6、24화48 h적혈기항(Cr)화뇨소담(BUN)수평;관찰재관주후48 h적신조직병리개변화신소관상피세포조망정황.결과 수주MSC자균가재신장중관찰도MSC,이관후조최다(P<0.05).재관주후24 h화48 h시,수주MSC자적혈Cr화BUN여가수술조비교,차이균무통계학의의(P>0.05),단균명현저우IR조(P<0.05).여IR조비교,수주MSC자적신장병리손상감경,세포조망수감소,이관후조적개선최위명현(P<0.05).결론수주MSC가감경대서신장적IRI,저일효응재재관주후수주MSC자최위명현,가능시통과감경염증반응화억제신소관세포조망래감경IRI.
Objective To observe the protection and distribution of bone marrow mesenchymal stem cells (MSCs) by distinct intravenous infusion time on renal ischemia reperfusion injury (IRI) in rats.Methods We used unilateral nephrectomy and contralateral vascular occlusion method to establish renal IRI model in rats.The experimental groups which received 2 × 106 MSCs infusion through the tail vein,were subsequently divided into 3 subgroups:2 h pre-reperfusion (PreOp,n =16),immediately after reperfusion (Op,n =16),6 h post-reperfusion (PostOp,n - 16).The control groups included sham operation group (n =16) and ischemia group (n =16).Chemotaxis of DAPI-labeled MSCs was detected 6 h after administration in the IR kidney.Renal function was detected at 6,24,and 48 h respectively after operation. Forty eight h after operation,the renal tissues were harvested to observe the pathological changes by HE staining and the tubular epithelial cell apoptosis via TUNEL assay.Results MSCs were found in the experimental groups after IR in the kidney,most in PostOp group.Twenty-four and 48 h after reperfusion,there was no significant difference in Cr and BUN between the experimental groups and sham operation group (P>0.05),but the levels of Cr and BUN in the experimental groups were significantly lower than in the IR group (P< 0.05). As compared with IR group,the renal pathological injury was alleviated,the number of apoptotic cells was decreased in the experimental group,most significantly in PostOp group (P<0.05).Conclusion MSCs can reduce the inflammatory response and inhibit renal tubular cell apoptosis in rat renal IRI.Post-reperfusion administration of MSCs leads to the best chemotaxis efficiency and protection.